Polymer Capital Management (Us) LLC Amicus Therapeutics, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $846 Billion
- Q2 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 46,562 shares of FOLD stock, worth $374,358. This represents 0.03% of its overall portfolio holdings.
Number of Shares
46,562Holding current value
$374,358% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
302Shares Held
331MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$236 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$234 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$196 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$145 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$118 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.26B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...